Sports Med device maker Mitek Sports Medicine’s gone all biotherapy on us with its newly announced launch of MONOVISC® High Molecular Weight Hyaluronan and the PEAK™ Platelet Rich Plasma (PRP) System, a new device that produces high quality PRP in only 2.5 minutes.
It’s American Orthopaedic Society for Sports Medicine (AOSSM) 2014 Annual Meeting week, an event that usually sees a raft of new product announcements. Not wishing to miss the opportunity, J&J’s Mitek division has launched its Monovisc single-injection treatment for knee pain related to osteoarthritis, together with the Peak system for delivering platelet-rich plasma. While these are both exclusive distribution agreements, the move signals the company broadening its spectrum of offerings to help sports medicine specialists provide personalized treatment for joint injuries related to sports and physical activity, as well as degenerative tissue conditions.
Hyaluronic acid treatment is certainly not a new option for degenerative osteoarthritic conditions of the knee, having been around in various forms for about twenty years now from memory. Monovisc is a single-injection hyaluronan treatment that can provide up to six months of pain relief and claims to help restore joint mobility in patients suffering from pain associated with the condition. It is injected directly into the knee to help replace the naturally occuring hyaluronan found in healthy joint fluid, and to cushion, protect and lubricate the knee joint.
Interestingly, Monovisc breaks the mould somewhat, being the only single-injection treatment with hyaluronic acid produced from a non-avian source, thereby reducing the risk for allergic reaction in some patients. Historically, hyaluronic acid has been harvested from cocks’ combs.
Mitek Sports Medicine is also now the exclusive marketer and distributor of the DSM Biomedical’s PEAK PRP System, which works by separating PRP from a sample of a patient’s own blood. The device consistently produces 3mL of high quality PRP from 27mL of whole blood in 2.5 minutes, yielding up to seven-times the normal concentration of platelets. The processing time is significantly less than competitor systems that have processing times ranging from 10 to 30 minutes. In addition, the Peak PRP System weighs only four pounds, making it smaller and more portable.
“Both products are important new early intervention options for sports medicine physicians and their patients,” said Peter Vitanzo, MD, Sports Medicine Specialist at the Rothman Institute in Philadelphia. “These products give us more non-operative tools to personalize the approach for the individual patient based on their level of activity, degree of injury and treatment preference.”
“Our goal with these single- and multiple-injection products, and our new PRP system, is to provide a range of options across the sports medicine patient continuum of care that help return patients to the activities they enjoy as quickly as possible,” said Ian Lawson, Worldwide President, Mitek Sports Medicine.
Source: Mitek Sports Medicine